Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1132969.RAsA-fSXo2oZz8dbR3hPa0Nx8tkNWDttnxE1r4VhHX4sQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1132969.RAsA-fSXo2oZz8dbR3hPa0Nx8tkNWDttnxE1r4VhHX4sQ130_assertion type Assertion NP1132969.RAsA-fSXo2oZz8dbR3hPa0Nx8tkNWDttnxE1r4VhHX4sQ130_head.
- NP1132969.RAsA-fSXo2oZz8dbR3hPa0Nx8tkNWDttnxE1r4VhHX4sQ130_assertion description "[The concept of using information from a patient's tumor to make therapeutic and treatment decisions has revolutionized the landscape for cancer care and research in general.Management of non-small-cell lung cancer, in particular, has seen several of these advances, with the understanding of activating mutations in EGFR, fusion genes involving ALK, rearrangements in ROS-1, and ongoing research in targeted therapies for K-RAS and MET.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1132969.RAsA-fSXo2oZz8dbR3hPa0Nx8tkNWDttnxE1r4VhHX4sQ130_provenance.
- NP1132969.RAsA-fSXo2oZz8dbR3hPa0Nx8tkNWDttnxE1r4VhHX4sQ130_assertion evidence source_evidence_literature NP1132969.RAsA-fSXo2oZz8dbR3hPa0Nx8tkNWDttnxE1r4VhHX4sQ130_provenance.
- NP1132969.RAsA-fSXo2oZz8dbR3hPa0Nx8tkNWDttnxE1r4VhHX4sQ130_assertion SIO_000772 24292963 NP1132969.RAsA-fSXo2oZz8dbR3hPa0Nx8tkNWDttnxE1r4VhHX4sQ130_provenance.
- NP1132969.RAsA-fSXo2oZz8dbR3hPa0Nx8tkNWDttnxE1r4VhHX4sQ130_assertion wasDerivedFrom befree-2016 NP1132969.RAsA-fSXo2oZz8dbR3hPa0Nx8tkNWDttnxE1r4VhHX4sQ130_provenance.
- NP1132969.RAsA-fSXo2oZz8dbR3hPa0Nx8tkNWDttnxE1r4VhHX4sQ130_assertion wasGeneratedBy ECO_0000203 NP1132969.RAsA-fSXo2oZz8dbR3hPa0Nx8tkNWDttnxE1r4VhHX4sQ130_provenance.